Roger Bresolí Obach

Roger Bresolí Obach is an active Researcher at the IQS School of Engineering, part of Universitat Ramon Llull, where he works in the Department of Analytical and Applied Chemistry as a Ramon y Cajal Researcher since 2023. His work spans multiple disciplines at the intersection of chemistry, photonics, and biomedical applications.

Dr. Bresolí Obach earned his Bachelor of Chemical Sciences (2013), Master's degree in Chemistry specializing in Pharmaceutical Chemistry (2014), and PhD in Chemistry (2018), all from Universitat Ramon Llull. His academic trajectory demonstrates a clear progression in photochemistry and its biomedical applications.

His primary research interests focus on photodynamic therapy, biological photochemistry, and the development of photofunctional materials. He specializes in near-infrared imaging methods, optical matter, and the application of reactive oxygen species in therapeutic contexts. His work bridges fundamental photochemistry with practical medical applications, particularly in cancer treatment and antimicrobial therapies.

Analysis of his publication record reveals a strong emphasis on nanoparticle-based solutions for biomedical challenges. His research shows increasing sophistication in manipulating light-matter interactions at the nanoscale, with applications ranging from cancer treatment to novel data storage technologies. The consistent focus on photosensitizers, optical properties of nanomaterials, and therapeutic applications demonstrates a cohesive research trajectory.

• Ramon y Cajal Researcher Position (Prestigious Spanish research fellowship)
• h-index of 19 according to Scopus metrics
• Extensive scientific production with 55 publications

Dr. Bresolí Obach leads multiple significant research projects including FASTCOMET (Future Data Storage Using Colloidal Memory Technology), LIGHTCOMPAS (exploring light-matter interactions), and the RyC-2021 Ramon y Cajal grant. He is also involved in the AppLightChem research group, which specializes in biomedical applications of photobiological chemistry, focusing on solar photoprotection, cancer photochemotherapy, photoantimicrobial therapies, and fluorescence imaging diagnostics. His collaborative work extends to the A Multidisciplinary SACRU Network for Antimicrobial Resistance research.

His laboratory work centers around the AppLightChem research group, which develops innovative approaches to photobiological applications. The group's work spans from fundamental photochemistry to applied biomedical solutions, with particular emphasis on translating laboratory discoveries into practical medical applications.